Subarachnoid Hemorrhage Withdrawn Phase 2 Trials for Sildenafil (DB00203)

Also known as: Subarachnoid bleeding / Subarachnoid haemorrhage / Subarachnoid hemorrhage NOS / Subarachnoid haemorrhage NOS / Haemorrhage subarachnoid / Hemorrhage subarachnoid

IndicationStatusPhase
DBCOND0029809 (Subarachnoid Hemorrhage)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00871065Safety Study of Sildenafil in Treatment of Cerebral Aneurysm VasospasmPrevention
NCT01091870Sildenafil for Prevention of Cerebral VasospasmPrevention